The A640G CYBA polymorphism associates with subclinical atherosclerosis in diabetes

Oxidative stress is implicated in diabetes. The NADPH oxidases are the main source of superoxide in phagocytic and vascular cells, and p22phox is a key subunit. Genetic variants of CYBA, the human p22phox gene, associate with cardiovascular disease. We investigated the association of the A640G polym...

ver descrição completa

Detalhes bibliográficos
Autores: Moreno-Zulategui, M.U. (María de Ujue)|||/items/c970940e-b812-4c54-b9ee-26a5e0b78ec7, San-José-Enériz, G. (Gorka)|||/items/362ac8c3-5d50-4383-9fc1-7abbed048387, Fortuño, A. (Ana)|||/items/2324831f-71b3-4d1b-afc1-594e4e1bc0c9, Miguel-Carrasco, J.L. (José Luis)|||/items/626cda34-5a0d-43e1-a34e-33d5f8c77fa6, Beloqui, O. (Óscar)|||/items/87d04a14-2d74-4221-8a57-12550777420d, Diez-Martinez, J. (Javier)|||/items/4f3a0e43-12bf-403d-9dc7-31fab0d11d41, Zalba-Goñi, G. (Guillermo)|||/items/71410fa2-baa5-4efc-bce7-14b4b0e23802
Tipo de documento: artigo
Data de publicação:2011
País:España
Recursos:Universidad de Navarra
Repositório:Dadun. Depósito Académico Digital de la Universidad de Navarra
Idioma:inglês
OAI Identifier:oai:dadun.unav.edu:10171/17937
Acesso em linha:https://hdl.handle.net/10171/17937
Access Level:Acceso aberto
Palavra-chave:Atherosclerosis
Diabetes
Intima-Media Thickness
NADPH oxidase
Oxidative stress
A640G polymorphism
id ES_9d4bfa9c08cdc731bcf207f8cea1e259
oai_identifier_str oai:dadun.unav.edu:10171/17937
network_acronym_str ES
network_name_str España
repository_id_str
spelling The A640G CYBA polymorphism associates with subclinical atherosclerosis in diabetesMoreno-Zulategui, M.U. (María de Ujue)|||/items/c970940e-b812-4c54-b9ee-26a5e0b78ec7San-José-Enériz, G. (Gorka)|||/items/362ac8c3-5d50-4383-9fc1-7abbed048387Fortuño, A. (Ana)|||/items/2324831f-71b3-4d1b-afc1-594e4e1bc0c9Miguel-Carrasco, J.L. (José Luis)|||/items/626cda34-5a0d-43e1-a34e-33d5f8c77fa6Beloqui, O. (Óscar)|||/items/87d04a14-2d74-4221-8a57-12550777420dDiez-Martinez, J. (Javier)|||/items/4f3a0e43-12bf-403d-9dc7-31fab0d11d41Zalba-Goñi, G. (Guillermo)|||/items/71410fa2-baa5-4efc-bce7-14b4b0e23802AtherosclerosisDiabetesIntima-Media ThicknessNADPH oxidaseOxidative stressA640G polymorphismOxidative stress is implicated in diabetes. The NADPH oxidases are the main source of superoxide in phagocytic and vascular cells, and p22phox is a key subunit. Genetic variants of CYBA, the human p22phox gene, associate with cardiovascular disease. We investigated the association of the A640G polymorphism with diabetes and its impact on phagocytic NADPH oxidase-dependent superoxide production and subclinical atherosclerosis. We studied 1212 subjects in which clinical parameters including carotid intima-media thickness (cIMT) were assessed. The A640G polymorphism was genotyped by TaqMan probes. In 496 subjects, the NADPH oxidase-dependent superoxide production in peripheral blood mononuclear cells was assessed by chemiluminescence. The GG genotype prevalence was significantly higher in type 2 diabetic patients than in non-diabetic subjects. Peripheral blood mononuclear cells from diabetic GG patients presented higher NADPH oxidase-dependent superoxide production than those of diabetic AA/AG patients. Within the diabetic group, GG patients presented higher cIMT levels than AA/AG patients. The A640G CYBA polymorphism may be a marker of oxidative stress risk and may be indicative of subclinical atherosclerosis in type 2 diabetes.Frontiers in BioscienceDadun. Depósito Académico Digital Universidad de Navarra20112011-05-1620112011-01-0120112011-01-01journal articlehttp://purl.org/coar/resource_type/c_6501info:eu-repo/semantics/articleapplication/pdfhttps://hdl.handle.net/10171/17937reponame:Dadun. Depósito Académico Digital de la Universidad de Navarrainstname:Universidad de NavarraInglésengopen accesshttp://purl.org/coar/access_right/c_abf2info:eu-repo/semantics/openAccessoai:dadun.unav.edu:10171/179372026-06-21T12:47:57Z
dc.title.none.fl_str_mv The A640G CYBA polymorphism associates with subclinical atherosclerosis in diabetes
title The A640G CYBA polymorphism associates with subclinical atherosclerosis in diabetes
spellingShingle The A640G CYBA polymorphism associates with subclinical atherosclerosis in diabetes
Moreno-Zulategui, M.U. (María de Ujue)|||/items/c970940e-b812-4c54-b9ee-26a5e0b78ec7
Atherosclerosis
Diabetes
Intima-Media Thickness
NADPH oxidase
Oxidative stress
A640G polymorphism
title_short The A640G CYBA polymorphism associates with subclinical atherosclerosis in diabetes
title_full The A640G CYBA polymorphism associates with subclinical atherosclerosis in diabetes
title_fullStr The A640G CYBA polymorphism associates with subclinical atherosclerosis in diabetes
title_full_unstemmed The A640G CYBA polymorphism associates with subclinical atherosclerosis in diabetes
title_sort The A640G CYBA polymorphism associates with subclinical atherosclerosis in diabetes
dc.creator.none.fl_str_mv Moreno-Zulategui, M.U. (María de Ujue)|||/items/c970940e-b812-4c54-b9ee-26a5e0b78ec7
San-José-Enériz, G. (Gorka)|||/items/362ac8c3-5d50-4383-9fc1-7abbed048387
Fortuño, A. (Ana)|||/items/2324831f-71b3-4d1b-afc1-594e4e1bc0c9
Miguel-Carrasco, J.L. (José Luis)|||/items/626cda34-5a0d-43e1-a34e-33d5f8c77fa6
Beloqui, O. (Óscar)|||/items/87d04a14-2d74-4221-8a57-12550777420d
Diez-Martinez, J. (Javier)|||/items/4f3a0e43-12bf-403d-9dc7-31fab0d11d41
Zalba-Goñi, G. (Guillermo)|||/items/71410fa2-baa5-4efc-bce7-14b4b0e23802
author Moreno-Zulategui, M.U. (María de Ujue)|||/items/c970940e-b812-4c54-b9ee-26a5e0b78ec7
author_facet Moreno-Zulategui, M.U. (María de Ujue)|||/items/c970940e-b812-4c54-b9ee-26a5e0b78ec7
San-José-Enériz, G. (Gorka)|||/items/362ac8c3-5d50-4383-9fc1-7abbed048387
Fortuño, A. (Ana)|||/items/2324831f-71b3-4d1b-afc1-594e4e1bc0c9
Miguel-Carrasco, J.L. (José Luis)|||/items/626cda34-5a0d-43e1-a34e-33d5f8c77fa6
Beloqui, O. (Óscar)|||/items/87d04a14-2d74-4221-8a57-12550777420d
Diez-Martinez, J. (Javier)|||/items/4f3a0e43-12bf-403d-9dc7-31fab0d11d41
Zalba-Goñi, G. (Guillermo)|||/items/71410fa2-baa5-4efc-bce7-14b4b0e23802
author_role author
author2 San-José-Enériz, G. (Gorka)|||/items/362ac8c3-5d50-4383-9fc1-7abbed048387
Fortuño, A. (Ana)|||/items/2324831f-71b3-4d1b-afc1-594e4e1bc0c9
Miguel-Carrasco, J.L. (José Luis)|||/items/626cda34-5a0d-43e1-a34e-33d5f8c77fa6
Beloqui, O. (Óscar)|||/items/87d04a14-2d74-4221-8a57-12550777420d
Diez-Martinez, J. (Javier)|||/items/4f3a0e43-12bf-403d-9dc7-31fab0d11d41
Zalba-Goñi, G. (Guillermo)|||/items/71410fa2-baa5-4efc-bce7-14b4b0e23802
author2_role author
author
author
author
author
author
dc.contributor.none.fl_str_mv Dadun. Depósito Académico Digital Universidad de Navarra
dc.subject.none.fl_str_mv Atherosclerosis
Diabetes
Intima-Media Thickness
NADPH oxidase
Oxidative stress
A640G polymorphism
topic Atherosclerosis
Diabetes
Intima-Media Thickness
NADPH oxidase
Oxidative stress
A640G polymorphism
description Oxidative stress is implicated in diabetes. The NADPH oxidases are the main source of superoxide in phagocytic and vascular cells, and p22phox is a key subunit. Genetic variants of CYBA, the human p22phox gene, associate with cardiovascular disease. We investigated the association of the A640G polymorphism with diabetes and its impact on phagocytic NADPH oxidase-dependent superoxide production and subclinical atherosclerosis. We studied 1212 subjects in which clinical parameters including carotid intima-media thickness (cIMT) were assessed. The A640G polymorphism was genotyped by TaqMan probes. In 496 subjects, the NADPH oxidase-dependent superoxide production in peripheral blood mononuclear cells was assessed by chemiluminescence. The GG genotype prevalence was significantly higher in type 2 diabetic patients than in non-diabetic subjects. Peripheral blood mononuclear cells from diabetic GG patients presented higher NADPH oxidase-dependent superoxide production than those of diabetic AA/AG patients. Within the diabetic group, GG patients presented higher cIMT levels than AA/AG patients. The A640G CYBA polymorphism may be a marker of oxidative stress risk and may be indicative of subclinical atherosclerosis in type 2 diabetes.
publishDate 2011
dc.date.none.fl_str_mv 2011
2011-05-16
2011
2011-01-01
2011
2011-01-01
dc.type.none.fl_str_mv journal article
http://purl.org/coar/resource_type/c_6501
dc.type.openaire.fl_str_mv info:eu-repo/semantics/article
format article
dc.identifier.none.fl_str_mv https://hdl.handle.net/10171/17937
url https://hdl.handle.net/10171/17937
dc.language.none.fl_str_mv Inglés
eng
language_invalid_str_mv Inglés
language eng
dc.rights.none.fl_str_mv open access
http://purl.org/coar/access_right/c_abf2
dc.rights.openaire.fl_str_mv info:eu-repo/semantics/openAccess
rights_invalid_str_mv open access
http://purl.org/coar/access_right/c_abf2
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Frontiers in Bioscience
publisher.none.fl_str_mv Frontiers in Bioscience
dc.source.none.fl_str_mv reponame:Dadun. Depósito Académico Digital de la Universidad de Navarra
instname:Universidad de Navarra
instname_str Universidad de Navarra
reponame_str Dadun. Depósito Académico Digital de la Universidad de Navarra
collection Dadun. Depósito Académico Digital de la Universidad de Navarra
repository.name.fl_str_mv
repository.mail.fl_str_mv
_version_ 1869414730973577216
score 15,301629